PulmoTech selected for Techleap COVID-19 program
Thursday 16 April 2020
- Life Cooperative
The Groningen-based company PulmoTech is one of the 8 selected startups for the Techleap COVID-19 program. The Techleap COVID-19 program has been launched to enable a select group of entrepreneurs to provide working solutions to the challenges of the current crisis because of the coronavirus. Many responses have been received to the program and today the 8 companies that will participate in the program have been announced. In addition to PulmoTech, amongst others UV Smart, Synappz and AirBliss + have also been selected.
The program provides assistance through our extensive network as well as insightful (online) sessions with leading experts. These Dutch startups alongside many of the others in the ecosystem can directly contribute to reducing the impact of COVID-19. It's now time for us as Techleap.nl and the ecosystem to support them. Giving them access to the resources they need and the visibility they deserve.
About PulmoTech
PulmoTech is developing a special catheter to better adjust ventilation of patients in intensive care. The PulmoTech catheter, an innovative tube with special sensors that is placed through the nose or mouth into the esophagus, allows the patient to measure the function of the respiratory muscles and lungs very accurately in the patient. PulmoTech is in the final phase of the clinical research program and is also preparing for the production phase by scaling up the prototype. The catheter is expected to be available to the market in mid-2021.
Source: techleap.nl , DvhN
Image: PulmoTech B.V.
Focus areas
Life CooperativeLatest news
-
Wednesday 3 April 2024
Founder Talks Life Sciences looks back on a successful eve..
-
Tuesday 20 February 2024
700,000 euros subsidy from PharmaNL for the development of..
-
Thursday 8 February 2024
Succesful matchmaking during Meet & Greet Life Science..
-
Tuesday 23 January 2024
Apply now for your SME Feasibility Voucher
-
Wednesday 17 January 2024
Sabiad secures investment from Pharma Connect Capital for ..
-
Tuesday 19 December 2023
Groundbreaking Results Cement North Netherlands' Role..
-
Wednesday 22 November 2023
UMCG, RUG and regional industries secure substantial grant..
-
Wednesday 27 September 2023
Necessity of medicine production in the Netherlands undisp..
-
Monday 25 September 2023
The consortium led by ParaMedir awarded around €600,00.00 ..
-
Thursday 14 September 2023
Discover your life long career in the Life Sciences!